Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 3271 AL 3285

Therapeutic Potential of Multifunctional Tacrine Analogues

Przybyłowska M, Kowalski S, Dzierzbicka K, Inkielewicz-Stepniak I.

Curr Neuropharmacol. 2019;17(5):472-490. doi: 10.2174/1570159X16666180412091908.

Methodologies Related to Computational Models in View of Developing Anti-Alzheimer Drugs: An Overview

Baheti K, Kale M.

Curr Drug Discov Technol. 2019;16(1):66-73. doi: 10.2174/1570163815666180417120833.

Viral Induced Oxidative and Inflammatory Response in Alzheimer's Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach

Talwar P, Gupta R, Kushwaha S, Agarwal R, Saso L, Kukreti S, Kukreti R.

Curr Neuropharmacol. 2019;17(4):352-365. doi: 10.2174/1570159X16666180419124508.

Drugs for Targeted Therapies of Alzheimer's Disease

Tam C, Wong JH, Ng TB, Tsui SKW, Zuo T.

Curr Med Chem. 2019;26(2):335-359. doi: 10.2174/0929867325666180430150940.

Aporphines and Alzheimer's Disease: Towards a Medical Approach Facing the Future

Nabavi SM, Uriarte E, Rastrelli L, Sobarzo-Sánchez E.

Curr Med Chem. 2019;26(18):3253-3259. doi: 10.2174/0929867325666180514102933.

A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease

Korabecny J, Spilovska K, Mezeiova E, Benek O, Juza R, Kaping D, Soukup O.

Curr Med Chem. 2019;26(30):5625-5648. doi: 10.2174/0929867325666180517094023.

Dantrolene : From Malignant Hyperthermia to Alzheimer's Disease

Shi Y, Wang Y, Wei H.

CNS Neurol Disord Drug Targets. 2019;18(9):668-676. doi: 10.2174/1871527317666180619162649.

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer's Disease

Talarico G, Trebbastoni A, Bruno G, de Lena C.

Curr Neuropharmacol. 2019;17(2):176-183. doi: 10.2174/1570159X16666180702144644.

Phytoconstituents and their Possible Mechanistic Profile for Alzheimer's Disease - A Literature Review

Basavan D, Chalichem NSS, Kumar MKS.

Curr Drug Targets. 2019;20(3):263-291. doi: 10.2174/1389450119666180813095637.

Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review

Alam J, Sharma L.

Curr Drug Targets. 2019;20(3):316-339. doi: 10.2174/1389450119666180820104723.

Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update

Hoskin JL, Al-Hasan Y, Sabbagh MN.

Nicotine Tob Res. 2019 Feb 18;21(3):370-376. doi: 10.1093/ntr/nty116.

Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update

Khan MA, Alam Q, Haque A, Ashafaq M, Khan MJ, Ashraf GM, Ahmad M.

Curr Neuropharmacol. 2019;17(3):232-246. doi: 10.2174/1570159X16666180828100002.

Supranutritional Sodium Selenate Supplementation Delivers Selenium to the Central Nervous System: Results from a Randomized Controlled Pilot Trial in Alzheimer's Disease

Cardoso BR, Roberts BR, Malpas CB, Vivash L, Genc S, Saling MM, Desmond P, Steward C, Hicks RJ, Callahan J, Brodtmann A, Collins S, Macfarlane S, Corcoran NM, Hovens CM, Velakoulis D, O'Brien TJ, Hare DJ, Bush AI.

Neurotherapeutics. 2019 Jan;16(1):192-202. doi: 10.1007/s13311-018-0662-z.

Curcuminoids and Novel Opportunities for the Treatment of Alzheimer's Disease: Which Molecules are Actually Effective?

Zholos AV, Moroz OF, Storozhuk MV.

Curr Mol Pharmacol. 2019;12(1):12-26. doi: 10.2174/1874467211666181012150847.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias